RECENT NEWS

Consultant histopathologist and medical examiner Suzy Lishman has been made a Dame in the King's New Year's Honours, for her work on the implementation of the national medical examiner service.

A new £2 million pilot scheme will see health visitors reach families facing barriers to vaccines, to ensure more children are protected.

Five new studies funded by the Medical Research Council (MRC) will investigate neurodegenerative diseases that give rise to dementia.

AI cancer diagnostics and precision oncology firm Lunit has announced that a new study evaluating its AI-powered pathology solution, Lunit SCOPE HER2, has been published, in which it demonstrates high concordance with pathologists in HER2 interpretation for advanced biliary tract cancer (cholangiocarcinoma).

US diagnostics firm Next Gen Diagnostics (NGD) has announced that it will spin off its Infection Prevention division into an independent company, NGD Infection Prevention, focused on the implementation of real-time genomic transmission detection across American hospitals.

Understanding gut microbiome interactions with medicines could help explain differences in how people respond to treatment and build on existing medicine safety knowledge to support safer, more effective prescribing in the future, according to a new review.

A new study analysing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated?

​MedTech Europe sees the European Commission’s targeted revision proposal of the EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) as a key milestone in bringing urgently needed reforms to Europe’s medical technology sector and most importantly for patients across the region.

The Government has accepted advice on eligibility from the Joint Committee on Vaccination and Immunisation (JCVI) for the spring 2026 COVID-19 vaccination programme.

New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer.

BD (Becton, Dickinson and Company) has announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.

Molecular diagnostics firm Alveo Technologies has announced a strategic partnership with Global Animal Health (GAH) to introduce the Alveo Sense Poultry Avian Influenza Test at broad scale across Egypt.

A large-scale population study which included a pTau217 blood test has demonstrated the feasibility of deploying blood tests at scale in population-level research, supporting earlier detection and treatment eligibility assessment.

The Royal College of Pathologists has responded to The Health Foundation’s NHS Productivity Commission call for evidence, highlighting pathology’s central role in patient care and proposing four practical reforms to unlock efficiency and resilience.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a ‘call for evidence’, asking for views on how AI in healthcare should be regulated.

The 2026 edition of the Biomedical Science Industry Handbook is available to read online now.

ALZpath – which develops diagnostic tools for Alzheimer's disease and related dementias – has announced a licensing agreement with Siemens Healthineers for use of its proprietary pTau217 antibody in the development of a pTau217 assay.

BD (Becton, Dickinson and Company) has announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following IVDR certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX System.

A multinational workshop for strengthening disease surveillance in Africa has revealed the persistent antibiotic resistance of cholera-causing bacteria on the continent.

The National Institute for Health and Care Excellence (NICE) has announced Professor Jonathan Benger CBE as incoming Chief Executive, taking over from Dr Samantha Roberts.